Our Customers.
World-Leading.
Forward Thinking.
Trusted. By World-Leading Companies.
Many of the world’s leading biopharmaceutical, biotech, CRO, and CDMO companies trust us with their most valuable resource — their data.
Click on the logos below. Learn more.
Global Top Biopharma
Biotech & Biopharma
CDMOs
CROs
Agrobio
Academic & Scientific Non-Profits
We especially appreciated the high level of expertise and support provided by Genedata, which enabled us to optimize every stage of our analytical processes—while incorporating industry best practices—and quickly generate high-quality results.
We are pleased to have found in Genedata a trusted and reliable partner who provided us with expert knowledge in big multi-omics data analysis to accelerate our search for precision biomarkers to prognosticate disease course and to guide early and effective personalized treatment decisions.
Since many of the biopharma and biotechs we work with as a CRDMO also use Genedata, it makes it even easier to exchange data with our customers. We are also very pleased with Genedata’s support and global presence, which gives us local access to support our operations both in Europe and the U.S.
Customer Stories
Pfizer Builds on the Genedata E2E Workflow Platform
Pfizer chose the Genedata platform to serve as a central data backbone and application environment upon which they could build tools to flexibly address Pfizer-specific requirements and drive innovation. Today, the system is used by over 250 people in 15 groups located at six Pfizer R&D sites globally, supporting 200+ distinct projects.
Roche Automates MS-Based Analytics of Novel Therapeutic Oligos
Roche describe how they implemented a streamlined data processing workflow for UV-LC-MS-based analysis of the large number of samples generated during optimization of oligonucleotide drug synthesis.
High-Throughput MS-Based Screening of Bispecific Antibodies
Using Genedata Expressionist®, scientists at Genmab established an automated MS-based high-throughput assay that provides qualitative and quantitative information on a DuoBody® bsAb preparation. Compared to the CEX-based process, data acquisition and processing times were reduced by 95% and the number of person hours dedicated to data processing was reduced by 70%.
Tech Notes
Scalable Transcriptomic Screening Analysis
Discover a new solution embedded within Genedata Screener® which allowed Janssen to rapidly and simultaneously analyze expression for 20 to 80 different genes per compound, measured in plate-based screens performed using the QuantiGene® RNA Assay.
Efficient & High Quality CHO Cell Line Development
This application note describes how Genedata Selector® has been used to analyze next generation sequencing (NGS) data from Cergentis' TLA technology in CHO cell line development and quality control.
End-to-End Workflow for HT Mass Screening
AstraZeneca integrated Genedata Expressionist®, an MS analysis software, to build an end-to-end HT-MS analysis workflow and Genedata Screener®, an analysis platform for in-vitro screening. These integrations enabled a 7-fold decrease in analysis time, preparing AstraZeneca to expand use of their innovative technology.
End-to-End Assay & Data Analysis Automation
The Genedata platform enables Roche to fully automate the analysis of lower throughput assays. They achieved end-to-end automation, including of the data analysis, allowing them to save significant time, improve data quality and result robustness.